Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue $ 24,168 $ 18,070
Cost of revenue 10,360 9,846
Gross profit 13,808 8,224
Operating expenses:    
Research and development 9,663 8,657
Sales and marketing 6,850 6,905
General and administrative 11,770 12,684
Total operating expenses 28,283 28,246
Loss from operations (14,475) (20,022)
Other income (expense):    
Interest income 565 14
Interest expense (4,578) (3,043)
Change in fair value of contingent earnout liability 76 6,883
Change in fair value of warrant liabilities 746 5,835
Foreign exchange 1,024 (935)
Other expense, net (762) (234)
Total other (expense) income, net (2,929) 8,520
Loss before income taxes (17,404) (11,502)
Income tax provision 269 290
Net loss $ (17,673) $ (11,792)
Net loss per share, Basic $ (0.12) $ (0.08)
Net loss per share, Diluted $ (0.12) $ (0.08)
Weighted Average Number of Shares Outstanding, Basic 144,770,908 139,274,538
Weighted Average Number of Shares Outstanding, Diluted 144,770,908 139,274,538